Oncology Based In-vivo CRO Market Estimated At USD 1.9 Billion By 2028
San Francisco, 18 Feb 2022: The Report Oncology Based In-vivo CRO Market Size, Share & Trends Analysis Report By Indication (Blood Cancer, Solid Tumor), By Model (Syngeneic Model, Patient Derived Xenograft (PDX), Xenograft), By Region, And Segment Forecasts, 2021 - 2028 The global oncology based in-vivo CRO market is expected to reach USD 1.9 billion by 2028, according to a new study by Grand View Research, Inc. It is expected to expand at a CAGR of 8.2% from 2021 to 2028. The use of Contract Research Organization (CRO) oncology services helps the manufacturers/sponsors to provide complete attention on the production capacity and at enhancing their in-house processes. Furthermore, the pressure from the increasing competition due to patent expirations, rapid growth of generics, and introduction of biosimilar equivalents are propelling the pharmaceutical companies to take the aid of such organizations. Hence, it can be predicted that the oncolog...